Delta-opioid receptor immunoreactivity on astrocytes is upregulated during mitosis

GLIA

Volumn 25, Issue 4, 1999, Pages 370-378

  Thorlin, Thorleif ^a   Persson, P Anders I ^a   Eriksson, Peter S ^a   Hansson, Elisabeth ^a   Rönnbäck, Lars ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Astrocytes; Cell cycle; Immunocytochemistry; Microtubule inhibitors; Nervous system development; Receptor regulation

Indexed keywords

DELTA OPIATE RECEPTOR; ENKEPHALIN; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE];

ANIMAL; ARTICLE; ASTROCYTE; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; MITOSIS; NEWBORN; PHYSIOLOGY; RAT; SPECTROFLUOROMETRY; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELLS, CULTURED; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; MITOSIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; SPECTROMETRY, FLUORESCENCE; UP-REGULATION;

EID: 0344699361     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(19990215)25:4<370::AID-GLIA6>3.0.CO;2-J     Document Type: Article

References (47)

1. Arvidsson U, Dado RJ, Reidl M, Lee, JH, Laws PY, Loh HH, Elde R, Wessendorf MW. 1995. δ-opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J Neurosci 15:1215-1235.
2. Dado RJ, Law PY, Loh HH, Elde R. 1993. Immunofluorescent identification of a delta (δ)-opioid receptor on primary afferent nerve terminals. Neuroreport 5:341-344.
3. Davila-Garcia MI, Azmitia EC. 1989. Effects of acute and chronic administration of Leu-enkephalin on cultured serotonergic neurons: evidence for opioids as inhibitory neuronal growth factors. Dev Brain Res 49:97-103.
4. Faissner A, Schachner M. 1996. Tenascin and janusin: glial recognition molecules involved in neural development and regeneration. In: Kettenmann H, Ransom BR, editors. Neuroglia. New York: Oxford University Press. p 411-426.
5. Ford, DF, Rhines RK. 1979. Prenatal exposure to methadone HCL in relationship to body and growth in the rat. Acta Neurol Scand 59:248-262.
6. 2+ mobilization, development, and the antiproliferative effects of opioids. Brain Res 737:175-187.
7. Hammer RP. 1993. Effects of opioids on the developing brain. In: Hammer RP, editor. The neurobiology of opiates. Boca Raton, FL: CRC Press, p 1-21.
8. Hansson E, Rönnbäck, L. 1989. Primary cultures of astroglia and neurons from different brain regions. In: Shahar A, de Vellis J, Vernadakis A, Haber B, editors. A dissection and tissue culture manual of the nervous system. New York: Alan R. Liss. p 92-104.
9. Hatten ME. 1990. Riding the glial monorail: a common mechanism for glial-guided neuronal migration in different regions of the developing brain. Trends Neurosci 13:179-181.
10. Hauser KF, Osborne JG, Stiene-Martin A, Meiner MH. 1990. Cellular localization of proenkephalin mRNA and enkephalin peptide products in cultured astrocytes. Brain Res 522:347-353.
11. Hauser KF, Stiene-Martin A. 1991. Characterization of opioid-dependent glial development in dissociated and organotypic cultures of mouse central nervous system: critical periods and target specificity. Dev Brain Res 62:245-255.
12. Jaffe LF. 1995. Calcium waves and development. Ciba Found Symp 188:4-17.
13. Ji RU, Zhang Q, Law P-Y, Low HH, Elde R, Hökfelt T. 1995. Expression of μ-, δ-, and κ-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 15:8156-8166.
14. Khatibi S, Blomstrand F, Muyderman H, Olsson T. 1996. Quantitative methods for the analysis of dynamic fluorescence images with application to astroglial cells. Technical Report CTH-TE-53, Chalmers University of Technology, p 1-37.
15. Kikuchi Y, Kita T, Miyauchi M, Kizawa I, Oomori K, Kato, K. 1987. Effects of naloxone on human ovarian cancer cell growth in vitro and in vivo. Jpn J Cancer Res 78:519-525.
16. Maderspach K, Németh K, Simon J, Sándor B, Szücs M, Wollemann M. 1991. A monoclonal antibody recognizing κ- but not μ- and δ-opioid receptors. J Neurochem 56:1897-1904.
17. Martin FC, Anton PA, Gornbein JA, Shanahan F, Merril, JE. 1993. Production of interleukin-1 by microglia in response to substance P: role for a non-classical NK-1 receptor. J Neuroimmunol 42:53-60.
18. McLaughlin PJ, Tobias SW, Lang CM, Zagon IS. 1997. Chronic exposure to the opioid antagonist naltrexone during pregnancy: maternal and offspring effects. Physiol Behav 62:501-508.
19. Meriney SD, Ford MJ, Olivia D, Pilar, G. 1991. Endogenous opioids modulate neuronal survival in the developing avian ciliary ganglion. J Neurosci 11:3705-3717.
20. Meshul CK, Seil FJ, Herndon RM. 1987. Astrocytes play a role in regulation of synaptic density. Brain Res 402:139-145.
21. Murgo AJ. 1989. Modulation of murine melanoma growth by naloxone. Cancer Lett 44:137-142.
22. 2+ transients in astrocytes. Neuroscience 54:605-614.
23. Ornatowska M, Glasel, JA. 1991. Stereospecificity of opiate receptors in a synchronized culture of NG 108-15 cells probed with fluorescent anti-idiotypic antibodies. Mol Pharmacol 40:354-359.
24. Perlmutter LS, Tweedle CD, Hatton GI. 1984. Neuronal/glial plastisity in the supraoptic dendritic zone: dendritic bundling and double synapse formation at parturition. Neuroscience 13:769-779.
25. Pfeiffer A, Herz A. 1984. Endocrine actions of opioids. Horm Metab Res 16:386-397.
26. Rakic P. 1981. Neuronal-glial interactions during brain development. Trends Neurosci 4:184-187.
27. Rakic P. 1990. Principles of neural cell migration. Experimenta 46:882-891.
28. Ricalde AR, Hammer RP. 1991. Perinatal opiate treatment delays growth of cortical dendrites. Neurosci Lett 115:137-143.
29. Scheideler MA, Lockney MW, Dawson G. 1983. Cell cycle-dependent expression of specific opiate binding with variable coupling to adenylate cyclase in a neurotumor cell line NG 108-15. J Neurochem 41:1261-1268.
30. Schmahl W, Funk R, Miaskowski U, Plendl J. 1989. Long-lasting effects of naltrexone, an opioid receptor antagonist, on cell proliferation in developing rat forebrain. Brain Res 486:297-300.
31. Schmidt P, Schröder H, Maderspach K, Staak M. 1994. Immunohistochemical localization of κ-opioid receptors in the human frontal cortex. Brain Res 654:223-233.
32. Shinoda H, Marini AM, Cosi C, Schwartz JP. 1989. Brain region and gene specificity of neuropeptide gene expression in cultured astrocytes. Science 245:415-417.
33. Silver J, Edwards MA, Levitt P. 1993. Immunocytochemical demonstration of early appearing astroglial structures that form boundaries and pathways along axon tracts in the fetal brain. J Comp Neurol 328:415-436.
34. Silver RB. 1996. Calcium, BOB's, QED's, microdomains and cellullar decision: control of mitotic cell division in sand dollar blastomeres. Cell Calcium 20:161-179.
35. Slotkin TA, Seidler FJ, Whitmore WL. 1980. Effects of maternal methadone administration on ornithine decarboxylase in brain and heart of the offspring: relationships of enzyme activity to dose and growth impairment in the rat. Life Sci 26:861-867.
36. Stiene-Martin A, Hauser KF. 1990. Opioid-dependent growth of glial cultures: suppression of astrocyte DNA synthesis by met-enkephaalin. Life Sci 46:91-98.
37. Stiene-Martin A, Gurwell JA, Hauser KF. 1991. Morphine alters astrocyte growth in primary cultures of mouse glial cells: evidence for a direct effect of opiates on neuronal maturation. Dev Brain Res 60:1-7.
38. Stiene-Martin A, Mattson MP, Hauser KF. 1993. Opiates selectively increase intracellular calcium in developing type-1 astrocytes: role of calcium in morphine-induced morphologic differentiation. Dev Brain Res 76:189-196.
39. Stiene-Martin A, Zhou R, Hauser KF. 1998. Regional, developmental, and cell cycle-dependent differences in μ, δ and κ-opioid receptor expression among cultured mouse astrocytes. Glia 22:249-259.
40. Thompson RC, Mansour A, Akil H, Watson SJ. 1993. Cloning and pharmacological characterization of a rat μ-opioid receptor. Neuron 11:903-913.
41. Vernadakis A, Gibson DA. 1985. Neurotoxicity of opiates during brain development: in vivo and in vitro studies. Prog Clin Biol Res 163C:245-253.
42. Vertes Z, Melegh G, Vertes M, Kovacs S. 1982. Effect of naloxone and D-Met2-Pro5-enkephalinamide treatment on the DNA synthesis in the developing rat brain. Life Sci 31:119-126.
43. Zagon IS, McLaughlin PJ. 1983. Increased brain size and cellular content in infant rats treated with an opiate antagonist. Science 221:1179-1180.
44. Zagon IS. McLaughlin PJ. 1990. Opioid antagonist naltrexone stimulation of cell proliferation in human and animal neuroblastoma and human fibrosarcoma cells in culture. Neurosience 37:223-226.
45. Zagon IS, McLaughlin PJ. 1991. Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system. Brain Res 542:318-323.
46. Zagon IS, Slotkin TA, eds. 1992. Maternal substance abuse and the developing nervous system. San Diego: Academic Press.
47. Zagon IS, Hytrek SD, McLaughlin PJ. 1996. Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture. Am J Physiol 271:R511-R518.